...
首页> 外文期刊>Molecular BioSystems >Prioritizing candidate disease miRNAs by integrating phenotype associations of multiple diseases with matched miRNA and mRNA expression profiles
【24h】

Prioritizing candidate disease miRNAs by integrating phenotype associations of multiple diseases with matched miRNA and mRNA expression profiles

机译:通过整合多种疾病的表型关联与匹配的miRNA和mRNA表达谱对候选疾病miRNA进行优先排序

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

MicroRNAs (miRNAs) have been validated to show widespread disruption of function in many cancers. However, despite concerted efforts to develop prioritization approaches based on a priori knowledge of disease-associated miRNAs, uncovering oncogene or tumor-suppressor miRNAs remains a challenge. Here, based on the assumption that diverse diseases with phenotype associations show similar molecular mechanisms, we present an approach for the systematic prioritization of disease-specific miRNAs by using known disease genes and context-dependent miRNA-target interactions derived from matched miRNA and mRNA expression data, independent of known disease miRNAs. After collecting matched miRNA and mRNA expression data for 11 cancer types, we applied this approach to systematically prioritize miRNAs involved in these cancers. Our approach yielded an average area under the ROC curve (AUC) of 75.84% according to known disease miRNAs from the miR2Disease database, with the highest AUC (80.93%) for pancreatic cancer. Moreover, we assessed the sensitivity and specificity as well as the integrative importance of this approach. Comparative analyses also showed that our method is comparable to previous methods. In summary, we provide a novel method for prioritization of disease-related miRNAs that can help researchers better understand the important roles of miRNAs in human disease.
机译:MicroRNA(miRNA)已被证实在许多癌症中显示出广泛的功能破坏。然而,尽管基于疾病相关miRNA的先验知识共同努力开发优先方法,但发现癌基因或肿瘤抑制miRNA仍然是一个挑战。在此,基于具有表型关联的多种疾病显示相似的分子机制的假设,我们提出了一种方法,该方法通过使用已知的疾病基因以及源自匹配的miRNA和mRNA表达的上下文相关miRNA-靶标相互作用来系统地区分疾病特异性miRNA数据,独立于已知的疾病miRNA。在收集了11种癌症的匹配的miRNA和mRNA表达数据后,我们应用了该方法来系统地确定参与这些癌症的miRNA的优先级。根据miR2Disease数据库中已知的疾病miRNA,我们的方法得出的ROC曲线下平均面积(AUC)为75.84%,其中胰腺癌的AUC最高(80.93%)。此外,我们评估了这种方法的敏感性和特异性以及综合重要性。比较分析还表明,我们的方法与以前的方法相当。总之,我们提供了一种对疾病相关miRNA进行优先级排序的新颖方法,可以帮助研究人员更好地了解miRNA在人类疾病中的重要作用。

著录项

  • 来源
    《Molecular BioSystems》 |2014年第11期|2800-2809|共10页
  • 作者单位

    College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China;

    College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China;

    College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China;

    College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China;

    College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China;

    College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China;

    College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China;

    College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号